Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia

NCT01597440 is registered in ClinicalTrials.gov with Mendel Tuchman as lead sponsor.

NCT NCT01597440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Lead sponsor
Mendel Tuchman
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2012
Completion date
February 28, 2015
Enrollment
1 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

methylmalonic acidemia, propionic acidemia